SPTCL is a rare T-cell lymphoma recognized by the new World Health Organization (WHO)-European Organization for Research and Treatment of Cancer (EORTC) classification for cutaneous lymphomas.[2] Lymphomas expressing TCR - αβ which is normally CD8 + and CD56 –, are restricted to the subcutaneous tissue and often run an indolent course. The gene discussed is NCAM1; the disease is T-cell non-Hodgkin lymphoma.